# Advancing Careers of Investigators in Primary Immune Disorders

> **NIH NIH U54** · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · 2020 · $12,823

## Abstract

PIDTC Career Enhancement Core – Abstract
The purpose of the Career Enhancement Core of the Primary Immune Deficiency Treatment Consortium
(PIDTC) is to provide career development that will enhance education at the clinical post-doctoral level. PIDTC
represents a unique consortium of stakeholders committed to investigating the optimal approach to the
management of rare primary immune deficiencies (PID). We have a robust training program to identify and
nurture trainees who need and value exposure to rare disease methodology and specifically with an interest in
PID. The PIDTC Career Enhancement program has been in existence since 2009 when the first Training Grants
were offered. Twenty awards have been made since that time and nearly all awardees have continued in rare
disease work in an academic setting. Most have pursued research careers. A central effort is directed at
providing Training Grants to support and stimulate interest in PID research. We additionally offer guidance on
careers, feedback on writing, networking and opportunities to interface with the RDCRN. Our annual meeting
offers opportunities to engage with faculty in the field and we proactively advance careers through the associated
Education Day at the meeting. This application will extend the work engaging fellows and young faculty in rare
disease methodology and provide a network of experienced faculty to promote and encourage a career in
treatment of PID. We have three Specific Aims to advance this important cause: 1) select the highest quality
candidates for research support in Primary Immune Deficiencies; 2) Incorporate Trainees and Junior Faculty of
consortium sites into PIDTC activities to enhance their education and networking opportunities, and 3) provide
education on methodology and outreach efforts for rare disease work. This integrated training program fosters
relationships with patient advocacy groups who represent the constituency we serve. This program also excels
and bringing together faculty of diverse backgrounds to ensure that transplant and other treatment modalities
are examined from the perspective of infectious diseases, hematologic and immunologic angles. The diversity
in PIDTC represents a model for advancing care through novel multidisciplinary approaches forged
collaboratively.

## Key facts

- **NIH application ID:** 10018655
- **Project number:** 5U54AI082973-12
- **Recipient organization:** UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
- **Principal Investigator:** KATHLEEN E SULLIVAN
- **Activity code:** U54 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $12,823
- **Award type:** 5
- **Project period:** 2009-09-12 → 2024-08-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10018655

## Citation

> US National Institutes of Health, RePORTER application 10018655, Advancing Careers of Investigators in Primary Immune Disorders (5U54AI082973-12). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/10018655. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*